medigraphic.com
Instituto Nacional de Salud Pública

2021, Number 6

<< Back Next >>

salud publica mex 2021; 63 (6)

Prevalence of Covid-19 sequelae in the National Health and Nutrition Survey 2020

Vidaña-Pérez D, López-Olmedo N, González-Morales R, Shamah-Levy T, Barrientos-Gutiérrez T

Language: English
References: 13
Page: 799-802
PDF size: 191.45 Kb.


ABSTRACT

Objective. To estimate the prevalence of Covid-19 sequelae and its association with sociodemographic and medical care characteristics. Materials and methods. Mexican adults that experienced Covid-19 symptoms and were seropositive to the N-protein of Sars-CoV-2 in the Ensanut 2020 responded to a question regarding sequelae. Associations were estimated using Poisson regression. Results. The prevalence of sequelae was 15.7%, being higher for people with higher education and who were hospitalized or treated at an emergency room during the acute Covid-19 phase. Conclusions. Self-reported sequelae associated to Covid-19 was frequent. Covid-19 sequelae could represent an important challenge for the health system and the Mexican society.


REFERENCES

  1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782-93. https://doi. org/10.1001/jama.2020.12839

  2. Lazcano-Ponce E, Alpuche-Aranda C. Alfabetización en salud pública ante la emergencia de la pandemia por Covid-19. Salud Publica Mex. 2020;62(3):331-40. https://doi.org/10.21149/11408

  3. Del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA. 2020;324(17):1723-4. https://doi.org/10.1001/ jama.2020.19719

  4. Lopez-Leon S, Wegman-Ostrosky T, Rebolledo P, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021;11:16144. https://doi.org/10.21203/ rs.3.rs-266574/v1

  5. Barrientos-Gutiérrez T, Alpuche-Aranda C, Lazcano-Ponce E, Pérez-Ferrer C, Rivera-Dommarco J. La salud pública en la primera ola: una agenda para la cooperación ante Covid-19. Salud Publica Mex. 2020;62(5):598- 606. https://doi.org/10.21149/11606

  6. Vidaña-Pérez D, López-Olmedo N, González-Morales R, Shamah-Levy T, Barrientos-Gutierrez T. Appendix Sequelae. Figshare. 2021. https://doi. org/10.6084/m9.figshare.16800034.v1

  7. Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista- Arredondo S, Lazcano-Ponce E, Martínez Barnetche J, et al. National Health and Nutrition Survey 2020 Covid-19 methodology. Salud Publica Mex. 2021;63(3):444-51. https://doi.org/10.21149/12580

  8. Dirección General de Epidemiología. Lineamiento estandarizado para la vigilancia epidemiológica y por laboratorio de la enfermedad respiratoria viral. Enero de 2021. Actualización de la Definición Operacional de Caso Sospechoso de Enfermedad Respiratoria Viral. México: SS, 2021 [cited August, 2021]. Available from: https://coronavirus.gob.mx/ wp-content/uploads/2021/02/Lineamiento_VE_y_Lab_Enf_Viral_Ene- 2021_290121.pdf

  9. Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021. Stat Bull. 2021:1-16 [cited August, 2021]. Available from: https://www. semiosis.at/wp-content/uploads/2021/06/Prevalence-of-ongoingsymptoms- following-coronavirus-COVID-19-infection-in-the-UK- 1-April-2021.pdf

  10. Agarwal V, Venkatakrishnan AJ, Puranik A, Lopez-Marquez A, O’horo JC, Badley AD, et al. Quantifying the prevalence of SARS-CoV-2 long-term shedding among non-hospitalized COVID-19 patients. Cell Death Discovery. 2020;138(6). https://doi.org/10.1038/s41420-020-00375-y

  11. Salinas-Escudero G, Carrillo-Vega MF, Granados-García V, Martínez- Valverde S, Toledano-Toledano F, Garduño-Espinosa J. A survival analysis of COVID-19 in the Mexican population. BMC Public Health. 2020;20:1616:1-8. Available from: https://bmcpublichealth.biomedcentral. com/articles/10.1186/s12889-020-09721-2

  12. Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biol Sex Differ. 2020;11(1):53:1- 11. https://doi.org/10.1186/s13293-020-00330-7

  13. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):16-25. https://doi.org/10.1016/j. jinf.2020.04.021




2020     |     www.medigraphic.com